<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36992283</PMID><DateRevised><Year>2023</Year><Month>04</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-393X</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>19</Day></PubDate></JournalIssue><Title>Vaccines</Title><ISOAbbreviation>Vaccines (Basel)</ISOAbbreviation></Journal><ArticleTitle>Regulatory T Cells (Tregs) and COVID-19: Unveiling the Mechanisms, and Therapeutic Potentialities with a Special Focus on Long COVID.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">699</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/vaccines11030699</ELocationID><Abstract><AbstractText>The COVID-19 pandemic has caused havoc all around the world. The causative agent of COVID-19 is the novel form of the coronavirus (CoV) named SARS-CoV-2, which results in immune system disruption, increased inflammation, and acute respiratory distress syndrome (ARDS). T cells have been important components of the immune system, which decide the fate of the COVID-19 disease. Recent studies have reported an important subset of T cells known as regulatory T cells (Tregs), which possess immunosuppressive and immunoregulatory properties and play a crucial role in the prognosis of COVID-19 disease. Recent studies have shown that COVID-19 patients have considerably fewer Tregs than the general population. Such a decrement may have an impact on COVID-19 patients in a number of ways, including diminishing the effect of inflammatory inhibition, creating an inequality in the Treg/Th17 percentage, and raising the chance of respiratory failure. Having fewer Tregs may enhance the likelihood of long COVID development in addition to contributing to the disease's poor prognosis. Additionally, tissue-resident Tregs provide tissue repair in addition to immunosuppressive and immunoregulatory activities, which may aid in the recovery of COVID-19 patients. The severity of the illness is also linked to abnormalities in the Tregs' phenotype, such as reduced expression of FoxP3 and other immunosuppressive cytokines, including IL-10 and TGF-beta. Hence, in this review, we summarize the immunosuppressive mechanisms and their possible roles in the prognosis of COVID-19 disease. Furthermore, the perturbations in Tregs have been associated with disease severity. The roles of Tregs are also explained in the long COVID. This review also discusses the potential therapeutic roles of Tregs in the management of patients with COVID-19.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dhawan</LastName><ForeName>Manish</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-7783-7138</Identifier><AffiliationInfo><Affiliation>Department of Microbiology, Punjab Agricultural University, Ludhiana 141004, India.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Trafford College, Altrincham, Manchester WA14 5PQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rabaan</LastName><ForeName>Ali A</ForeName><Initials>AA</Initials><Identifier Source="ORCID">0000-0002-6774-9847</Identifier><AffiliationInfo><Affiliation>Molecular Diagnostic Laboratory, Johns Hopkins Aramco Healthcare, Dhahran 31311, Saudi Arabia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Public Health and Nutrition, The University of Haripur, Haripur 22610, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alwarthan</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam 34212, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alhajri</LastName><ForeName>Mashael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam 34212, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Halwani</LastName><ForeName>Muhammad A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology, Faculty of Medicine, Al Baha University, Al Baha 4781, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alshengeti</LastName><ForeName>Amer</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-6861-6934</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, College of Medicine, Taibah University, Al-Madinah 41491, Saudi Arabia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infection Prevention and Control, Prince Mohammad Bin Abdulaziz Hospital, National Guard Health Affairs, Al-Madinah 41491, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Najim</LastName><ForeName>Mustafa A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Medical Laboratories Technology, College of Applied Medical Sciences, Taibah University, Al-Madinah 41411, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alwashmi</LastName><ForeName>Ameen S S</ForeName><Initials>ASS</Initials><Identifier Source="ORCID">0000-0002-7290-8945</Identifier><AffiliationInfo><Affiliation>Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah 51452, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alshehri</LastName><ForeName>Ahmad A</ForeName><Initials>AA</Initials><Identifier Source="ORCID">0000-0002-3143-3023</Identifier><AffiliationInfo><Affiliation>Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Najran University, Najran 61441, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alshamrani</LastName><ForeName>Saleh A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Najran University, Najran 61441, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>AlShehail</LastName><ForeName>Bashayer M</ForeName><Initials>BM</Initials><Identifier Source="ORCID">0000-0003-2372-9462</Identifier><AffiliationInfo><Affiliation>Pharmacy Practice Department, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam 31441, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garout</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Community Medicine and Health Care for Pilgrims, Faculty of Medicine, Umm Al-Qura University, Makkah 21955, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Abdulhadi</LastName><ForeName>Saleh</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-6585-4002</Identifier><AffiliationInfo><Affiliation>Department of Medical Laboratory Sciences, College of Applied Medical Sciences, Prince Sattam Bin Abdulaziz University, Riyadh 11942, Saudi Arabia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dr. Saleh Office for Medical Genetic and Genetic Counseling Services, The House of Expertise, Prince Sattam Bin Abdulaziz University, Dammam 32411, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Ahmed</LastName><ForeName>Shamsah H</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Specialty Paediatric Medicine, Qatif Central Hospital, Qatif 32654, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thakur</LastName><ForeName>Nanamika</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>University Institute of Biotechnology, Department of Biotechnology, Chandigarh University, Mohali 140413, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verma</LastName><ForeName>Geetika</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Experimental Medicine and Biotechnology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh 160012, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Vaccines (Basel)</MedlineTA><NlmUniqueID>101629355</NlmUniqueID><ISSNLinking>2076-393X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">T regulatory cells (Tregs)</Keyword><Keyword MajorTopicYN="N">immune response</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">therapeutics</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>31</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>30</Day><Hour>1</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36992283</ArticleId><ArticleId IdType="pmc">PMC10059134</ArticleId><ArticleId IdType="doi">10.3390/vaccines11030699</ArticleId><ArticleId IdType="pii">vaccines11030699</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alahdal M., Elkord E. Exhaustion and Over-Activation of Immune Cells in COVID-19: Challenges and Therapeutic Opportunities. Clin. Immunol. 2022;245:109177. doi: 10.1016/j.clim.2022.109177.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2022.109177</ArticleId><ArticleId IdType="pmc">PMC9640209</ArticleId><ArticleId IdType="pubmed">36356848</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhawan M., Saied A.A., Mitra S., Alhumaydhi F.A., Emran T.B., Wilairatana P. Omicron Variant (B.1.1.529) and Its Sublineages: What Do We Know so Far amid the Emergence of Recombinant Variants of SARS-CoV-2? Biomed. Pharmacother. 2022;154:113522. doi: 10.1016/j.biopha.2022.113522.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2022.113522</ArticleId><ArticleId IdType="pmc">PMC9376347</ArticleId><ArticleId IdType="pubmed">36030585</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad S., Hatmal M.M., Lambuk L., Al-Hatamleh M.A.I., Alshaer W., Mohamud R. The Role of TNFR2+ Tregs in COVID-19: An Overview and a Potential Therapeutic Strategy. Life Sci. 2021;286:120063. doi: 10.1016/j.lfs.2021.120063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2021.120063</ArticleId><ArticleId IdType="pmc">PMC8523334</ArticleId><ArticleId IdType="pubmed">34673116</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed J.Q., Maulud S.Q., Dhawan M., Priyanka , Choudhary O.P., Jalal P.J., Ali R.K., Tayib G.A., Hasan D.A. MicroRNAs in the Development of Potential Therapeutic Targets against COVID-19: A Narrative Review. J. Infect. Public Health. 2022;15:788&#x2013;799. doi: 10.1016/j.jiph.2022.06.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2022.06.012</ArticleId><ArticleId IdType="pmc">PMC9221922</ArticleId><ArticleId IdType="pubmed">35751930</ArticleId></ArticleIdList></Reference><Reference><Citation>Tandel N., Negi S., Dalai S.K., Tyagi R.K. Role of natural killer and B cell interaction in inducing pathogen specific immune responses. Int. Rev. Immunol. 2023 doi: 10.1080/08830185.2023.2172406. advance online publication .</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08830185.2023.2172406</ArticleId><ArticleId IdType="pubmed">36731424</ArticleId></ArticleIdList></Reference><Reference><Citation>Kudlay D., Kofiadi I., Khaitov M. Peculiarities of the T Cell Immune Response in COVID-19. Vaccines. 2022;10:242. doi: 10.3390/vaccines10020242.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10020242</ArticleId><ArticleId IdType="pmc">PMC8877307</ArticleId><ArticleId IdType="pubmed">35214700</ArticleId></ArticleIdList></Reference><Reference><Citation>Moss P. The T Cell Immune Response against SARS-CoV-2. Nat. Immunol. 2022;23:186&#x2013;193. doi: 10.1038/s41590-021-01122-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01122-w</ArticleId><ArticleId IdType="pubmed">35105982</ArticleId></ArticleIdList></Reference><Reference><Citation>Chavda V.P., Mishra T., Vuppu S. Immunological Studies to Understand Hybrid/Recombinant Variants of SARS-CoV-2. Vaccines. 2022;11:45. doi: 10.3390/vaccines11010045.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11010045</ArticleId><ArticleId IdType="pmc">PMC9867374</ArticleId><ArticleId IdType="pubmed">36679891</ArticleId></ArticleIdList></Reference><Reference><Citation>Arish M., Qian W., Narasimhan H., Sun J. COVID-19 Immunopathology: From Acute Diseases to Chronic Sequelae. J. Med. Virol. 2022;95:e28122. doi: 10.1002/jmv.28122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28122</ArticleId><ArticleId IdType="pmc">PMC9537925</ArticleId><ArticleId IdType="pubmed">36056655</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Chandrashekar A., Sellers D., Barrett J., Jacob-Dolan C., Lifton M., McMahan K., Sciacca M., VanWyk H., Wu C., et al. Vaccines Elicit Highly Conserved Cellular Immunity to SARS-CoV-2 Omicron. Nature. 2022;603:493&#x2013;496. doi: 10.1038/s41586-022-04465-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04465-y</ArticleId><ArticleId IdType="pmc">PMC8930761</ArticleId><ArticleId IdType="pubmed">35102312</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Chen D., Yuan D., Lausted C., Choi J., Dai C.L., Voillet V., Duvvuri V.R., Scherler K., Troisch P., et al. Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19. Cell. 2020;183:1479&#x2013;1495.e20. doi: 10.1016/j.cell.2020.10.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.10.037</ArticleId><ArticleId IdType="pmc">PMC7598382</ArticleId><ArticleId IdType="pubmed">33171100</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathew D., Giles J.R., Baxter A.E., Oldridge D.A., Greenplate A.R., Wu J.E., Alanio C., Kuri-Cervantes L., Pampena M.B., D&#x2019;Andrea K., et al. Deep Immune Profiling of COVID-19 Patients Reveals Distinct Immunotypes with Therapeutic Implications. Science. 2020;369:eabc8511. doi: 10.1126/science.abc8511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc8511</ArticleId><ArticleId IdType="pmc">PMC7402624</ArticleId><ArticleId IdType="pubmed">32669297</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhawan M., Rabaan A.A., Fawarah M.M.A., Almuthree S.A., Alsubki R.A., Alfaraj A.H., Mashraqi M.M., Alshamrani S.A., Abduljabbar W.A., Alwashmi A.S.S., et al. Updated Insights into the T Cell-Mediated Immune Response against SARS-CoV-2: A Step towards Efficient and Reliable Vaccines. Vaccines. 2023;11:101. doi: 10.3390/vaccines11010101.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11010101</ArticleId><ArticleId IdType="pmc">PMC9861463</ArticleId><ArticleId IdType="pubmed">36679947</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Bert N., Clapham H.E., Tan A.T., Chia W.N., Tham C.Y.L., Lim J.M., Kunasegaran K., Tan L.W.L., Dutertre C.-A., Shankar N., et al. Highly Functional Virus-Specific Cellular Immune Response in Asymptomatic SARS-CoV-2 Infection. J. Exp. Med. 2021;218:e20202617. doi: 10.1084/jem.20202617.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20202617</ArticleId><ArticleId IdType="pmc">PMC7927662</ArticleId><ArticleId IdType="pubmed">33646265</ArticleId></ArticleIdList></Reference><Reference><Citation>Grau-Exp&#xf3;sito J., S&#xe1;nchez-Gaona N., Massana N., Suppi M., Astorga-Gamaza A., Perea D., Rosado J., Falc&#xf3; A., Kirkegaard C., Torrella A., et al. Peripheral and Lung Resident Memory T Cell Responses against SARS-CoV-2. Nat. Commun. 2021;12:3010. doi: 10.1038/s41467-021-23333-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-23333-3</ArticleId><ArticleId IdType="pmc">PMC8140108</ArticleId><ArticleId IdType="pubmed">34021148</ArticleId></ArticleIdList></Reference><Reference><Citation>Goswami T.K., Singh M., Dhawan M., Mitra S., Emran T.B., Rabaan A.A., Mutair A.A., Alawi Z.A., Alhumaid S., Dhama K. Regulatory T Cells (Tregs) and Their Therapeutic Potential against Autoimmune Disorders&#x2014;Advances and Challenges. Hum. Vaccines Immunother. 2022;18:2035117. doi: 10.1080/21645515.2022.2035117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2022.2035117</ArticleId><ArticleId IdType="pmc">PMC9009914</ArticleId><ArticleId IdType="pubmed">35240914</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao M., Liu Y., Guo M., Wang Q., Wang Y., Fan J., Shen Y., Hou J., Wan Y., Zhu Z. Regulatory CD4+ and CD8+ T Cells Are Negatively Correlated with CD4+/CD8+ T Cell Ratios in Patients Acutely Infected with SARS-CoV-2. J. Leukoc. Biol. 2020;109:91&#x2013;97. doi: 10.1002/JLB.5COVA0720-421RR.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JLB.5COVA0720-421RR</ArticleId><ArticleId IdType="pmc">PMC10016821</ArticleId><ArticleId IdType="pubmed">32930458</ArticleId></ArticleIdList></Reference><Reference><Citation>Hillaire M., Rimmelzwaan G., Kreijtz J. Clearance of Influenza Virus Infections by T Cells: Risk of Collateral Damage? Curr. Opin. Virol. 2013;3:430&#x2013;437. doi: 10.1016/j.coviro.2013.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2013.05.002</ArticleId><ArticleId IdType="pubmed">23721864</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Wang Z., Cao W., Wu Q., Yuan Y., Zhang X. Regulatory T Cells in COVID-19. Aging Dis. 2021;12:1545. doi: 10.14336/AD.2021.0709.</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/AD.2021.0709</ArticleId><ArticleId IdType="pmc">PMC8460308</ArticleId><ArticleId IdType="pubmed">34631206</ArticleId></ArticleIdList></Reference><Reference><Citation>Galv&#xe1;n-Pe&#xf1;a S., Leon J., Chowdhary K., Michelson D.A., Vijaykumar B., Yang L., Magnuson A.M., Chen F., Manickas-Hill Z., Piechocka-Trocha A., et al. Profound Treg Perturbations Correlate with COVID-19 Severity. Proc. Natl. Acad. Sci. USA. 2021;118:e2111315118. doi: 10.1073/pnas.2111315118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2111315118</ArticleId><ArticleId IdType="pmc">PMC8449354</ArticleId><ArticleId IdType="pubmed">34433692</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Zheng J., Islam M.S., Yang Y., Hu Y., Chen X. The Role of CD4+FoxP3+ Regulatory T Cells in the Immunopathogenesis of COVID-19: Implications for Treatment. Int. J. Biol. Sci. 2021;17:1507&#x2013;1520. doi: 10.7150/ijbs.59534.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.59534</ArticleId><ArticleId IdType="pmc">PMC8071774</ArticleId><ArticleId IdType="pubmed">33907514</ArticleId></ArticleIdList></Reference><Reference><Citation>Seepathomnarong P., Ongarj J., Sophonmanee R., Seeyankem B., Chusri S., Surasombatpattana S., Pinpathomrat N. Regulatory T Cells Decreased during Recovery from Mild COVID-19. Viruses. 2022;14:1688. doi: 10.3390/v14081688.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14081688</ArticleId><ArticleId IdType="pmc">PMC9415862</ArticleId><ArticleId IdType="pubmed">36016311</ArticleId></ArticleIdList></Reference><Reference><Citation>Haunhorst S., Bloch W., Javelle F., Kr&#xfc;ger K., Baumgart S., Drube S., Lemh&#xf6;fer C., Reuken P., Stallmach A., M&#xfc;ller M., et al. A Scoping Review of Regulatory T Cell Dynamics in Convalescent COVID-19 Patients&#x2014;Indications for Their Potential Involvement in the Development of Long COVID? Front. Immunol. 2022;13:107099. doi: 10.3389/fimmu.2022.1070994.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1070994</ArticleId><ArticleId IdType="pmc">PMC9792979</ArticleId><ArticleId IdType="pubmed">36582234</ArticleId></ArticleIdList></Reference><Reference><Citation>Baecher-Allan C., Brown J.A., Freeman G.J., Hafler D.A. CD4+CD25high Regulatory Cells in Human Peripheral Blood. J. Immunol. 2001;167:1245&#x2013;1253. doi: 10.4049/jimmunol.167.3.1245.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.167.3.1245</ArticleId><ArticleId IdType="pubmed">11466340</ArticleId></ArticleIdList></Reference><Reference><Citation>Maekawa D., Riblet S.M., Whang P., Hurley D.J., Garcia M. Activation of Cytotoxic Lymphocytes and Presence of Regulatory T Cells in the Trachea of Non-Vaccinated and Vaccinated Chickens as a Recall to an Infectious Laryngotracheitis Virus (ILTV) Challenge. Vaccines. 2021;9:865. doi: 10.3390/vaccines9080865.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9080865</ArticleId><ArticleId IdType="pmc">PMC8402403</ArticleId><ArticleId IdType="pubmed">34451989</ArticleId></ArticleIdList></Reference><Reference><Citation>Panduro M., Benoist C., Mathis D. Tissue Tregs. Annu. Rev. Immunol. 2016;34:609&#x2013;633. doi: 10.1146/annurev-immunol-032712-095948.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-032712-095948</ArticleId><ArticleId IdType="pmc">PMC4942112</ArticleId><ArticleId IdType="pubmed">27168246</ArticleId></ArticleIdList></Reference><Reference><Citation>McRitchie B.R., Akkaya B. Exhaust the Exhausters: Targeting Regulatory T Cells in the Tumor Microenvironment. Front. Immunol. 2022;13:5820. doi: 10.3389/fimmu.2022.940052.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.940052</ArticleId><ArticleId IdType="pmc">PMC9562032</ArticleId><ArticleId IdType="pubmed">36248808</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnuson A.M., Kiner E., Ergun A., Park J.S., Asinovski N., Ortiz-Lopez A., Kilcoyne A., Paoluzzi-Tomada E., Weissleder R., Mathis D., et al. Identification and Validation of a Tumor-Infiltrating Treg Transcriptional Signature Conserved across Species and Tumor Types. Proc. Natl. Acad. Sci. USA. 2018;115:E10672&#x2013;E10681. doi: 10.1073/pnas.1810580115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1810580115</ArticleId><ArticleId IdType="pmc">PMC6233093</ArticleId><ArticleId IdType="pubmed">30348759</ArticleId></ArticleIdList></Reference><Reference><Citation>Lund J.M., Hsing L., Pham T.T., Rudensky A.Y. Coordination of Early Protective Immunity to Viral Infection by Regulatory T Cells. Science. 2008;320:1220&#x2013;1224. doi: 10.1126/science.1155209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1155209</ArticleId><ArticleId IdType="pmc">PMC2519146</ArticleId><ArticleId IdType="pubmed">18436744</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z., Jiang X., Dai X., Li B. The Dynamic Role of FOXP3+ Tregs and Their Potential Therapeutic Applications During SARS-CoV-2 Infection. Front. Immunol. 2022;13:916411. doi: 10.3389/fimmu.2022.916411.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.916411</ArticleId><ArticleId IdType="pmc">PMC9305488</ArticleId><ArticleId IdType="pubmed">35874688</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakaguchi S., Sakaguchi N., Asano M., Itoh M., Toda M. Immunologic Self-Tolerance Maintained by Activated T Cells Expressing IL-2 Receptor Alpha-Chains (CD25). Breakdown of a Single Mechanism of Self-Tolerance Causes Various Autoimmune Diseases. J. Immunol. 1995;155:1151&#x2013;1164. doi: 10.4049/jimmunol.155.3.1151.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.155.3.1151</ArticleId><ArticleId IdType="pubmed">7636184</ArticleId></ArticleIdList></Reference><Reference><Citation>Zenclussen A.C., Gerlof K., Zenclussen M.L., Ritschel S., Zambon Bertoja A., Fest S., Hontsu S., Ueha S., Matsushima K., Leber J., et al. Regulatory T Cells Induce a Privileged Tolerant Microenvironment at the Fetal-Maternal Interface. Eur. J. Immunol. 2006;36:82&#x2013;94. doi: 10.1002/eji.200535428.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.200535428</ArticleId><ArticleId IdType="pubmed">16358362</ArticleId></ArticleIdList></Reference><Reference><Citation>Palomares O., R&#xfc;ckert B., Jartti T., K&#xfc;c&#xfc;ksezer U.C., Puhakka T., Gomez E., Fahrner H.B., Speiser A., Jung A., Kwok W.W., et al. Induction and Maintenance of Allergen-Specific FOXP3+ Treg Cells in Human Tonsils as Potential First-Line Organs of Oral Tolerance. J. Allergy Clin. Immunol. 2012;129:510&#x2013;520.e9. doi: 10.1016/j.jaci.2011.09.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2011.09.031</ArticleId><ArticleId IdType="pubmed">22051696</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Ianni M., Falzetti F., Carotti A., Terenzi A., Castellino F., Bonifacio E., Del Papa B., Zei T., Ostini R.I., Cecchini D., et al. Tregs Prevent GVHD and Promote Immune Reconstitution in HLA-Haploidentical Transplantation. Blood. 2011;117:3921&#x2013;3928. doi: 10.1182/blood-2010-10-311894.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2010-10-311894</ArticleId><ArticleId IdType="pubmed">21292771</ArticleId></ArticleIdList></Reference><Reference><Citation>Traxinger B.R., Richert-Spuhler L.E., Lund J.M. Mucosal Tissue Regulatory T Cells Are Integral in Balancing Immunity and Tolerance at Portals of Antigen Entry. Mucosal Immunol. 2022;15:398&#x2013;407. doi: 10.1038/s41385-021-00471-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41385-021-00471-x</ArticleId><ArticleId IdType="pmc">PMC8628059</ArticleId><ArticleId IdType="pubmed">34845322</ArticleId></ArticleIdList></Reference><Reference><Citation>Shevach E.M., Thornton A.M. tTregs, pTregs, and iTregs: Similarities and Differences. Immunol. Rev. 2014;259:88&#x2013;102. doi: 10.1111/imr.12160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12160</ArticleId><ArticleId IdType="pmc">PMC3982187</ArticleId><ArticleId IdType="pubmed">24712461</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W., Putnam A.L., Xu-yu Z., Szot G.L., Lee M.R., Zhu S., Gottlieb P.A., Kapranov P., Gingeras T.R., de St. Groth B.F., et al. CD127 Expression Inversely Correlates with FoxP3 and Suppressive Function of Human CD4+ T Reg Cells. J. Exp. Med. 2006;203:1701&#x2013;1711. doi: 10.1084/jem.20060772.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20060772</ArticleId><ArticleId IdType="pmc">PMC2118339</ArticleId><ArticleId IdType="pubmed">16818678</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyagi R.K., Jacobse J., Li J., Allaman M.M., Otipoby K.L., Sampson E.R., Wilson K.T., Goettel J.A. HLA-Restriction of Human Treg Cells Is Not Required for Therapeutic Efficacy of Low-Dose IL-2 in Humanized Mice. Front. Immunol. 2021;12:630204. doi: 10.3389/fimmu.2021.630204.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.630204</ArticleId><ArticleId IdType="pmc">PMC7945590</ArticleId><ArticleId IdType="pubmed">33717161</ArticleId></ArticleIdList></Reference><Reference><Citation>Akkaya B., Shevach E.M. Regulatory T Cells: Master Thieves of the Immune System. Cell. Immunol. 2020;355:104160. doi: 10.1016/j.cellimm.2020.104160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellimm.2020.104160</ArticleId><ArticleId IdType="pmc">PMC9761694</ArticleId><ArticleId IdType="pubmed">32711171</ArticleId></ArticleIdList></Reference><Reference><Citation>Shevach E.M. Mechanisms of Foxp3+ T Regulatory Cell-Mediated Suppression. Immunity. 2009;30:636&#x2013;645. doi: 10.1016/j.immuni.2009.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2009.04.010</ArticleId><ArticleId IdType="pubmed">19464986</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao X., Cai S.F., Fehniger T.A., Song J., Collins L.I., Piwnica-Worms D.R., Ley T.J. Granzyme B and Perforin Are Important for Regulatory T Cell-Mediated Suppression of Tumor Clearance. Immunity. 2007;27:635&#x2013;646. doi: 10.1016/j.immuni.2007.08.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2007.08.014</ArticleId><ArticleId IdType="pubmed">17919943</ArticleId></ArticleIdList></Reference><Reference><Citation>Borsellino G., Kleinewietfeld M., Di Mitri D., Sternjak A., Diamantini A., Giometto R., H&#xf6;pner S., Centonze D., Bernardi G., Dell&#x2019;Acqua M.L., et al. Expression of Ectonucleotidase CD39 by Foxp3+ Treg Cells: Hydrolysis of Extracellular ATP and Immune Suppression. Blood. 2007;110:1225&#x2013;1232. doi: 10.1182/blood-2006-12-064527.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2006-12-064527</ArticleId><ArticleId IdType="pubmed">17449799</ArticleId></ArticleIdList></Reference><Reference><Citation>Deaglio S., Dwyer K.M., Gao W., Friedman D., Usheva A., Erat A., Chen J.-F., Enjyoji K., Linden J., Oukka M., et al. Adenosine Generation Catalyzed by CD39 and CD73 Expressed on Regulatory T Cells Mediates Immune Suppression. J. Exp. Med. 2007;204:1257&#x2013;1265. doi: 10.1084/jem.20062512.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20062512</ArticleId><ArticleId IdType="pmc">PMC2118603</ArticleId><ArticleId IdType="pubmed">17502665</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyagi R.K., Miles B., Parmar R., Garg N.K., Dalai S.K., Baban B., Cutler C.W. Human IDO-competent, long-lived immunoregulatory dendritic cells induced by intracellular pathogen, and their fate in humanized mice. Sci. Rep. 2017;7:41083. doi: 10.1038/srep41083.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep41083</ArticleId><ArticleId IdType="pmc">PMC5309771</ArticleId><ArticleId IdType="pubmed">28198424</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarek P.E., Huang C.-T., Lutz E.R., Kowalski J., Horton M.R., Linden J., Drake C.G., Powell J.D. A2A Receptor Signaling Promotes Peripheral Tolerance by Inducing T-Cell Anergy and the Generation of Adaptive Regulatory T Cells. Blood. 2008;111:251&#x2013;259. doi: 10.1182/blood-2007-03-081646.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2007-03-081646</ArticleId><ArticleId IdType="pmc">PMC2200810</ArticleId><ArticleId IdType="pubmed">17909080</ArticleId></ArticleIdList></Reference><Reference><Citation>Qureshi O.S., Zheng Y., Nakamura K., Attridge K., Manzotti C., Schmidt E.M., Baker J., Jeffery L.E., Kaur S., Briggs Z., et al. Trans-Endocytosis of CD80 and CD86: A Molecular Basis for the Cell-Extrinsic Function of CTLA-4. Science. 2011;332:600&#x2013;603. doi: 10.1126/science.1202947.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1202947</ArticleId><ArticleId IdType="pmc">PMC3198051</ArticleId><ArticleId IdType="pubmed">21474713</ArticleId></ArticleIdList></Reference><Reference><Citation>Fallarino F., Grohmann U., Hwang K.W., Orabona C., Vacca C., Bianchi R., Belladonna M.L., Fioretti M.C., Alegre M.-L., Puccetti P. Modulation of Tryptophan Catabolism by Regulatory T Cells. Nat. Immunol. 2003;4:1206&#x2013;1212. doi: 10.1038/ni1003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni1003</ArticleId><ArticleId IdType="pubmed">14578884</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan Z., Garg S.K., Banerjee R. Regulatory T Cells Interfere with Glutathione Metabolism in Dendritic Cells and T Cells. J. Biol. Chem. 2010;285:41525&#x2013;41532. doi: 10.1074/jbc.M110.189944.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.189944</ArticleId><ArticleId IdType="pmc">PMC3009879</ArticleId><ArticleId IdType="pubmed">21037289</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang B., Workman C., Lee J., Chew C., Dale B.M., Colonna L., Flores M., Li N., Schweighoffer E., Greenberg S., et al. Regulatory T Cells Inhibit Dendritic Cells by Lymphocyte Activation Gene-3 Engagement of MHC Class II. J. Immunol. 2008;180:5916&#x2013;5926. doi: 10.4049/jimmunol.180.9.5916.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.180.9.5916</ArticleId><ArticleId IdType="pubmed">18424711</ArticleId></ArticleIdList></Reference><Reference><Citation>Gotot J., Gottschalk C., Leopold S., Knolle P.A., Yagita H., Kurts C., Ludwig-Portugall I. Regulatory T Cells Use Programmed Death 1 Ligands to Directly Suppress Autoreactive B Cells in Vivo. Proc. Natl. Acad. Sci. USA. 2012;109:10468&#x2013;10473. doi: 10.1073/pnas.1201131109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1201131109</ArticleId><ArticleId IdType="pmc">PMC3387068</ArticleId><ArticleId IdType="pubmed">22689978</ArticleId></ArticleIdList></Reference><Reference><Citation>Samaan E., Elmaria M.O., Khedr D., Gaber T., Elsayed A.G., Shenouda R.N., Gamal H., Shahin D., Abousamra N.K., Shemies R. Characterization of Regulatory T Cells in SARS-CoV-2 Infected Hemodialysis Patients: Relation to Clinical and Radiological Severity. BMC Nephrol. 2022;23:391. doi: 10.1186/s12882-022-03024-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12882-022-03024-x</ArticleId><ArticleId IdType="pmc">PMC9730673</ArticleId><ArticleId IdType="pubmed">36476424</ArticleId></ArticleIdList></Reference><Reference><Citation>Vick S.C., Frutoso M., Mair F., Konecny A.J., Greene E., Wolf C.R., Logue J.K., Franko N.M., Boonyaratanakornkit J., Gottardo R., et al. A Regulatory T Cell Signature Distinguishes the Immune Landscape of COVID-19 Patients from Those with Other Respiratory Infections. Sci. Adv. 2021;7:eabj0274. doi: 10.1126/sciadv.abj0274.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abj0274</ArticleId><ArticleId IdType="pmc">PMC8580318</ArticleId><ArticleId IdType="pubmed">34757794</ArticleId></ArticleIdList></Reference><Reference><Citation>Ronit A., Berg R.M.G., Bay J.T., Haugaard A.K., Ahlstr&#xf6;m M.G., Burgdorf K.S., Ullum H., R&#xf8;rvig S.B., Tjelle K., Foss N.B., et al. Compartmental Immunophenotyping in COVID-19 ARDS: A Case Series. J. Allergy Clin. Immunol. 2021;147:81&#x2013;91. doi: 10.1016/j.jaci.2020.09.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2020.09.009</ArticleId><ArticleId IdType="pmc">PMC7581505</ArticleId><ArticleId IdType="pubmed">32979342</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J., Zhong M., Hong K., Yang Q., Zhang E., Zhou D., Xia J., Chen Y., Sun M., Zhao B., et al. Characteristics of T-cell Responses in COVID-19 Patients with Prolonged SARS-CoV-2 Positivity&#x2014;A Cohort Study. Clin. Transl. Immunol. 2021;10:e1259. doi: 10.1002/cti2.1259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cti2.1259</ArticleId><ArticleId IdType="pmc">PMC7932004</ArticleId><ArticleId IdType="pubmed">33728049</ArticleId></ArticleIdList></Reference><Reference><Citation>De Biasi S., Meschiari M., Gibellini L., Bellinazzi C., Borella R., Fidanza L., Gozzi L., Iannone A., Lo Tartaro D., Mattioli M., et al. Marked T Cell Activation, Senescence, Exhaustion and Skewing towards TH17 in Patients with COVID-19 Pneumonia. Nat. Commun. 2020;11:3434. doi: 10.1038/s41467-020-17292-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17292-4</ArticleId><ArticleId IdType="pmc">PMC7338513</ArticleId><ArticleId IdType="pubmed">32632085</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng H., Li H., Guo L., Liang Y., Li J., Wang X., Hu Y., Wang L., Liao Y., Yang F., et al. Virulence and Pathogenesis of SARS-CoV-2 Infection in Rhesus Macaques: A Nonhuman Primate Model of COVID-19 Progression. PLOS Pathog. 2020;16:e1008949. doi: 10.1371/journal.ppat.1008949.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1008949</ArticleId><ArticleId IdType="pmc">PMC7660522</ArticleId><ArticleId IdType="pubmed">33180882</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajamanickam A., Pavan Kumar N., Pandiaraj A.N., Selvaraj N., Munisankar S., Renji R.M., Venkataramani V., Murhekar M., Thangaraj J.W.V., Muthusamy S.K., et al. Characterization of memory T cell subsets and common &#x3b3;-chain cytokines in convalescent COVID-19 individuals. J. Leukoc. Biol. 2022;112:201&#x2013;212. doi: 10.1002/JLB.5COVA0721-392RR.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JLB.5COVA0721-392RR</ArticleId><ArticleId IdType="pmc">PMC9088480</ArticleId><ArticleId IdType="pubmed">35258122</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmoud Salehi Khesht A., Karpisheh V., Qubais Saeed B., Olegovna Zekiy A., Yapanto L.M., Nabi Afjadi M., Aksoun M., Nasr Esfahani M., Aghakhani F., Movahed M., et al. Different T Cell Related Immunological Profiles in COVID-19 Patients Compared to Healthy Controls. Int. Immunopharmacol. 2021;97:107828. doi: 10.1016/j.intimp.2021.107828.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2021.107828</ArticleId><ArticleId IdType="pmc">PMC8162824</ArticleId><ArticleId IdType="pubmed">34091116</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadeghi A., Tahmasebi S., Mahmood A., Kuznetsova M., Valizadeh H., Taghizadieh A., Nazemiyeh M., Aghebati-Maleki L., Jadidi-Niaragh F., Abbaspour-Aghdam S., et al. Th17 and Treg Cells Function in SARS-CoV2 Patients Compared with Healthy Controls. J. Cell. Physiol. 2020;236:2829&#x2013;2839. doi: 10.1002/jcp.30047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.30047</ArticleId><ArticleId IdType="pubmed">32926425</ArticleId></ArticleIdList></Reference><Reference><Citation>Meckiff B.J., Ram&#xed;rez-Su&#xe1;stegui C., Fajardo V., Chee S.J., Kusnadi A., Simon H., Eschweiler S., Grifoni A., Pelosi E., Weiskopf D., et al. Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4+ T Cells in COVID-19. Cell. 2020;183:1340&#x2013;1353.e16. doi: 10.1016/j.cell.2020.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.10.001</ArticleId><ArticleId IdType="pmc">PMC7534589</ArticleId><ArticleId IdType="pubmed">33096020</ArticleId></ArticleIdList></Reference><Reference><Citation>Caldrer S., Mazzi C., Bernardi M., Prato M., Ronzoni N., Rodari P., Angheben A., Piubelli C., Tiberti N. Regulatory T Cells as Predictors of Clinical Course in Hospitalised COVID-19 Patients. Front. Immunol. 2021;12:5143. doi: 10.3389/fimmu.2021.789735.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.789735</ArticleId><ArticleId IdType="pmc">PMC8674838</ArticleId><ArticleId IdType="pubmed">34925369</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin C., Zhou L., Hu Z., Zhang S., Yang S., Tao Y., Xie C., Ma K., Shang K., Wang W., et al. Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China. Clin. Infect. Dis. 2020;71:762&#x2013;768. doi: 10.1093/cid/ciaa248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa248</ArticleId><ArticleId IdType="pmc">PMC7108125</ArticleId><ArticleId IdType="pubmed">32161940</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Su B., Pang L., Qiao L., Feng Y., Ouyang Y., Guo X., Shi H., Wei F., Su X., et al. High-Dimensional Immune Profiling by Mass Cytometry Revealed Immunosuppression and Dysfunction of Immunity in COVID-19 Patients. Cell. Mol. Immunol. 2020;17:650&#x2013;652. doi: 10.1038/s41423-020-0447-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-0447-2</ArticleId><ArticleId IdType="pmc">PMC7186533</ArticleId><ArticleId IdType="pubmed">32346099</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia R., Wang X., Liu P., Liang X., Ge Y., Tian H., Chang H., Zhou H., Zeng M., Xu J. Mild Cytokine Elevation, Moderate CD4+&#x2009;T Cell Response and Abundant Antibody Production in Children with COVID-19. Virol. Sin. 2020;35:734&#x2013;743. doi: 10.1007/s12250-020-00265-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12250-020-00265-8</ArticleId><ArticleId IdType="pmc">PMC7373847</ArticleId><ArticleId IdType="pubmed">32699972</ArticleId></ArticleIdList></Reference><Reference><Citation>Szabo P.A., Dogra P., Gray J.I., Wells S.B., Connors T.J., Weisberg S.P., Krupska I., Matsumoto R., Poon M.M.L., Idzikowski E., et al. Longitudinal Profiling of Respiratory and Systemic Immune Responses Reveals Myeloid Cell-Driven Lung Inflammation in Severe COVID-19. Immunity. 2021;54:797&#x2013;814.e6. doi: 10.1016/j.immuni.2021.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2021.03.005</ArticleId><ArticleId IdType="pmc">PMC7951561</ArticleId><ArticleId IdType="pubmed">33765436</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Y., Arvey A., Chinen T., van der Veeken J., Gasteiger G., Rudensky A.Y. Control of the Inheritance of Regulatory T Cell Identity by a Cis Element in the Foxp3 Locus. Cell. 2014;158:749&#x2013;763. doi: 10.1016/j.cell.2014.07.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2014.07.031</ArticleId><ArticleId IdType="pmc">PMC4151558</ArticleId><ArticleId IdType="pubmed">25126783</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X.O., Nurieva R., Martinez G.J., Kang H.S., Chung Y., Pappu B.P., Shah B., Chang S.H., Schluns K.S., Watowich S.S., et al. Molecular Antagonism and Plasticity of Regulatory and Inflammatory T Cell Programs. Immunity. 2008;29:44&#x2013;56. doi: 10.1016/j.immuni.2008.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2008.05.007</ArticleId><ArticleId IdType="pmc">PMC2630532</ArticleId><ArticleId IdType="pubmed">18585065</ArticleId></ArticleIdList></Reference><Reference><Citation>Simsek A., Kizmaz M.A., Cagan E., Dombaz F., Tezcan G., Asan A., Demir H.I., Bal S.H., Ermis D.Y., Dilektasl&#x131; A.G., et al. Assessment of CD39 Expression in Regulatory T-cell Subsets by Disease Severity in Adult and Juvenile COVID-19 Cases. J. Med. Virol. 2022;94:2089&#x2013;2101. doi: 10.1002/jmv.27593.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27593</ArticleId><ArticleId IdType="pmc">PMC9015412</ArticleId><ArticleId IdType="pubmed">35032133</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahern D.J., Ai Z., Ainsworth M., Allan C., Allcock A., Angus B., Ansari M.A., Arancibia-C&#xe1;rcamo C.V., Aschenbrenner D., Attar M., et al. A Blood Atlas of COVID-19 Defines Hallmarks of Disease Severity and Specificity. Cell. 2022;185:916&#x2013;938.e58. doi: 10.1016/j.cell.2022.01.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.012</ArticleId><ArticleId IdType="pmc">PMC8776501</ArticleId><ArticleId IdType="pubmed">35216673</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen G., Wu D., Guo W., Cao Y., Huang D., Wang H., Wang T., Zhang X., Chen H., Yu H., et al. Clinical and Immunological Features of Severe and Moderate Coronavirus Disease 2019. J. Clin. Investig. 2020;130:2620&#x2013;2629. doi: 10.1172/JCI137244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI137244</ArticleId><ArticleId IdType="pmc">PMC7190990</ArticleId><ArticleId IdType="pubmed">32217835</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan L., Wang Q., Zhang D., Ding J., Huang Q., Tang Y.-Q., Wang Q., Miao H. Lymphopenia Predicts Disease Severity of COVID-19: A Descriptive and Predictive Study. Signal Transduct. Target. Ther. 2020;5:33. doi: 10.1038/s41392-020-0148-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-0148-4</ArticleId><ArticleId IdType="pmc">PMC7100419</ArticleId><ArticleId IdType="pubmed">32296069</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren X., Wen W., Fan X., Hou W., Su B., Cai P., Li J., Liu Y., Tang F., Zhang F., et al. COVID-19 Immune Features Revealed by a Large-Scale Single-Cell Transcriptome Atlas. Cell. 2021;184:5838. doi: 10.1016/j.cell.2021.10.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.10.023</ArticleId><ArticleId IdType="pmc">PMC8582084</ArticleId><ArticleId IdType="pubmed">34767776</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen X.-R., Geng R., Li Q., Chen Y., Li S.-F., Wang Q., Min J., Yang Y., Li B., Jiang R.-D., et al. ACE2-Independent Infection of T Lymphocytes by SARS-CoV-2. Signal Transduct. Target. Ther. 2022;7:83. doi: 10.1038/s41392-022-00919-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-00919-x</ArticleId><ArticleId IdType="pmc">PMC8914143</ArticleId><ArticleId IdType="pubmed">35277473</ArticleId></ArticleIdList></Reference><Reference><Citation>Kratzer B., Trapin D., Ettel P., K&#xf6;rm&#xf6;czi U., Rottal A., Tuppy F., Feichter M., Gattinger P., Borochova K., Dorofeeva Y., et al. Immunological Imprint of COVID-19 on Human Peripheral Blood Leukocyte Populations. Allergy. 2020;76:751&#x2013;765. doi: 10.1111/all.14647.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14647</ArticleId><ArticleId IdType="pmc">PMC7984452</ArticleId><ArticleId IdType="pubmed">33128792</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohebbi S.R., Baghaei K., Rostami-Nejad M., Mojarad E.N., Mirjalali H., Yadegar A., Asri N., Abdoulahi S., Assadzadeh Aghdaei H. Significant Changes of CD4, FOXP3, CD25, and IL6 Expression Level in Iranian COVID-19 Patients. Gastroenterol. Hepatol. Bed Bench. 2020;13:388&#x2013;392.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7682958</ArticleId><ArticleId IdType="pubmed">33244382</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalfaoglu B., Almeida-Santos J., Tye C.A., Satou Y., Ono M. T-Cell Hyperactivation and Paralysis in Severe COVID-19 Infection Revealed by Single-Cell Analysis. Front. Immunol. 2020;11:589380. doi: 10.3389/fimmu.2020.589380.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.589380</ArticleId><ArticleId IdType="pmc">PMC7596772</ArticleId><ArticleId IdType="pubmed">33178221</ArticleId></ArticleIdList></Reference><Reference><Citation>Thibaudin M., Fumet J.-D., Bon M., Hampe L., Limagne E., Ghiringhelli F. Immunological Features of Coronavirus Disease 2019 in Patients with Cancer. Eur. J. Cancer. 2020;139:70&#x2013;80. doi: 10.1016/j.ejca.2020.08.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejca.2020.08.013</ArticleId><ArticleId IdType="pmc">PMC7476569</ArticleId><ArticleId IdType="pubmed">32977223</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta S., Su H., Narsai T., Agrawal S. SARS-CoV-2-Associated T-Cell Responses in the Presence of Humoral Immunodeficiency. Int. Arch. Allergy Immunol. 2021;182:195&#x2013;209. doi: 10.1159/000514193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000514193</ArticleId><ArticleId IdType="pmc">PMC7900460</ArticleId><ArticleId IdType="pubmed">33486489</ArticleId></ArticleIdList></Reference><Reference><Citation>Corthay A. How Do Regulatory T Cells Work? Scand. J. Immunol. 2009;70:326&#x2013;336. doi: 10.1111/j.1365-3083.2009.02308.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-3083.2009.02308.x</ArticleId><ArticleId IdType="pmc">PMC2784904</ArticleId><ArticleId IdType="pubmed">19751267</ArticleId></ArticleIdList></Reference><Reference><Citation>Dejaco C., Duftner C., Grubeck-Loebenstein B., Schirmer M. Imbalance of Regulatory T Cells in Human Autoimmune Diseases. Immunology. 2006;117:289&#x2013;300. doi: 10.1111/j.1365-2567.2005.02317.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2567.2005.02317.x</ArticleId><ArticleId IdType="pmc">PMC1782226</ArticleId><ArticleId IdType="pubmed">16476048</ArticleId></ArticleIdList></Reference><Reference><Citation>Komatsu N., Okamoto K., Sawa S., Nakashima T., Oh-hora M., Kodama T., Tanaka S., Bluestone J.A., Takayanagi H. Pathogenic Conversion of Foxp3+ T Cells into TH17 Cells in Autoimmune Arthritis. Nat. Med. 2013;20:62&#x2013;68. doi: 10.1038/nm.3432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.3432</ArticleId><ArticleId IdType="pubmed">24362934</ArticleId></ArticleIdList></Reference><Reference><Citation>Jasim S.A., Mahdi R.S., Bokov D.O., Najm M.A.A., Sobirova G.N., Bafoyeva Z.O., Taifi A., Alkadir O.K.A., Mustafa Y.F., Mirzaei R., et al. The Deciphering of the Immune Cells and Marker Signature in COVID-19 Pathogenesis: An Update. J. Med. Virol. 2022;94:5128&#x2013;5148. doi: 10.1002/jmv.28000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28000</ArticleId><ArticleId IdType="pmc">PMC9350195</ArticleId><ArticleId IdType="pubmed">35835586</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown B., Ojha V., Fricke I., Al-Sheboul S.A., Imarogbe C., Gravier T., Green M., Peterson L., Koutsaroff I.P., Demir A., et al. Innate and Adaptive Immunity during SARS-CoV-2 Infection: Biomolecular Cellular Markers and Mechanisms. Vaccines. 2023;11:408. doi: 10.3390/vaccines11020408.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11020408</ArticleId><ArticleId IdType="pmc">PMC9962967</ArticleId><ArticleId IdType="pubmed">36851285</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann J., Prezzemolo T., Vanderbeke L., Roca C.P., Gerbaux M., Janssens S., Willemsen M., Burton O., Van Mol P., Van Herck Y., et al. Increased IL-10-producing Regulatory T Cells Are Characteristic of Severe Cases of COVID-19. Clin. Transl. Immunol. 2020;9:e1204. doi: 10.1002/cti2.1204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cti2.1204</ArticleId><ArticleId IdType="pmc">PMC7662088</ArticleId><ArticleId IdType="pubmed">33209300</ArticleId></ArticleIdList></Reference><Reference><Citation>Filbin M.R., Mehta A., Schneider A.M., Kays K.R., Guess J.R., Gentili M., Fenyves B.G., Charland N.C., Gonye A.L.K., Gushterova I., et al. Longitudinal Proteomic Analysis of Severe COVID-19 Reveals Survival-Associated Signatures, Tissue-Specific Cell Death, and Cell-Cell Interactions. Cell Rep. Med. 2021;2:100287. doi: 10.1016/j.xcrm.2021.100287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2021.100287</ArticleId><ArticleId IdType="pmc">PMC8091031</ArticleId><ArticleId IdType="pubmed">33969320</ArticleId></ArticleIdList></Reference><Reference><Citation>LIU M., GUO S., STILES J.K. The Emerging Role of CXCL10 in Cancer (Review) Oncol. Lett. 2011;2:583&#x2013;589. doi: 10.3892/ol.2011.300.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ol.2011.300</ArticleId><ArticleId IdType="pmc">PMC3406435</ArticleId><ArticleId IdType="pubmed">22848232</ArticleId></ArticleIdList></Reference><Reference><Citation>Veiga-Parga T., Sehrawat S., Rouse B.T. Role of Regulatory T Cells during Virus Infection. Immunol. Rev. 2013;255:182&#x2013;196. doi: 10.1111/imr.12085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12085</ArticleId><ArticleId IdType="pmc">PMC3748387</ArticleId><ArticleId IdType="pubmed">23947355</ArticleId></ArticleIdList></Reference><Reference><Citation>Sehrawat S., Rouse B.T. Tregs and Infections: On the Potential Value of Modifying Their Function. J. Leukoc. Biol. 2011;90:1079&#x2013;1087. doi: 10.1189/jlb.0611271.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.0611271</ArticleId><ArticleId IdType="pmc">PMC3236550</ArticleId><ArticleId IdType="pubmed">21914856</ArticleId></ArticleIdList></Reference><Reference><Citation>Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., Weiner H.L., Kuchroo V.K. Reciprocal Developmental Pathways for the Generation of Pathogenic Effector TH17 and Regulatory T Cells. Nature. 2006;441:235&#x2013;238. doi: 10.1038/nature04753.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature04753</ArticleId><ArticleId IdType="pubmed">16648838</ArticleId></ArticleIdList></Reference><Reference><Citation>Sefik E., Geva-Zatorsky N., Oh S., Konnikova L., Zemmour D., McGuire A.M., Burzyn D., Ortiz-Lopez A., Lobera M., Yang J., et al. Individual Intestinal Symbionts Induce a Distinct Population of ROR&#x3b3;+ Regulatory T Cells. Science. 2015;349:993&#x2013;997. doi: 10.1126/science.aaa9420.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaa9420</ArticleId><ArticleId IdType="pmc">PMC4700932</ArticleId><ArticleId IdType="pubmed">26272906</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohnmacht C., Park J.-H., Cording S., Wing J.B., Atarashi K., Obata Y., Gaboriau-Routhiau V., Marques R., Dulauroy S., Fedoseeva M., et al. The Microbiota Regulates Type 2 Immunity through ROR&#x3b3;t+ T Cells. Science. 2015;349:989&#x2013;993. doi: 10.1126/science.aac4263.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aac4263</ArticleId><ArticleId IdType="pubmed">26160380</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagenstein J., Melderis S., Nosko A., Warkotsch M.T., Richter J.V., Ramcke T., Herrnstadt G.R., Scheller J., Yan I., Mittr&#xfc;cker H.-W., et al. A Novel Role for IL-6 Receptor Classic Signaling: Induction of ROR&#x3b3;t+Foxp3+ Tregs with Enhanced Suppressive Capacity. J. Am. Soc. Nephrol. 2019;30:1439&#x2013;1453. doi: 10.1681/ASN.2019020118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2019020118</ArticleId><ArticleId IdType="pmc">PMC6683717</ArticleId><ArticleId IdType="pubmed">31311828</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimoto M., Nakano M., Terabe F., Kawahata H., Ohkawara T., Han Y., Ripley B., Serada S., Nishikawa T., Kimura A., et al. The Influence of Excessive IL-6 Production In Vivo on the Development and Function of Foxp3+ Regulatory T Cells. J. Immunol. 2011;186:32&#x2013;40. doi: 10.4049/jimmunol.0903314.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0903314</ArticleId><ArticleId IdType="pubmed">21106853</ArticleId></ArticleIdList></Reference><Reference><Citation>Mijnheer G., Lutter L., Mokry M., van der Wal M., Scholman R., Fleskens V., Pandit A., Tao W., Wekking M., Vervoort S., et al. Conserved Human Effector Treg Cell Transcriptomic and Epigenetic Signature in Arthritic Joint Inflammation. Nat. Commun. 2021;12:2710. doi: 10.1038/s41467-021-22975-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-22975-7</ArticleId><ArticleId IdType="pmc">PMC8113485</ArticleId><ArticleId IdType="pubmed">33976194</ArticleId></ArticleIdList></Reference><Reference><Citation>Arpaia N., Green J.A., Moltedo B., Arvey A., Hemmers S., Yuan S., Treuting P.M., Rudensky A.Y. A Distinct Function of Regulatory T Cells in Tissue Protection. Cell. 2015;162:1078&#x2013;1089. doi: 10.1016/j.cell.2015.08.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.08.021</ArticleId><ArticleId IdType="pmc">PMC4603556</ArticleId><ArticleId IdType="pubmed">26317471</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison O.J., Srinivasan N., Pott J., Schiering C., Krausgruber T., Ilott N.E., Maloy K.J. Epithelial-Derived IL-18 Regulates Th17 Cell Differentiation and Foxp3+ Treg Cell Function in the Intestine. Mucosal Immunol. 2015;8:1226&#x2013;1236. doi: 10.1038/mi.2015.13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mi.2015.13</ArticleId><ArticleId IdType="pmc">PMC4368110</ArticleId><ArticleId IdType="pubmed">25736457</ArticleId></ArticleIdList></Reference><Reference><Citation>Harb H., Benamar M., Lai P.S., Contini P., Griffith J.W., Crestani E., Schmitz-Abe K., Chen Q., Fong J., Marri L., et al. Notch4 Signaling Limits Regulatory T-Cell-Mediated Tissue Repair and Promotes Severe Lung Inflammation in Viral Infections. Immunity. 2021;54:1186&#x2013;1199.e7. doi: 10.1016/j.immuni.2021.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2021.04.002</ArticleId><ArticleId IdType="pmc">PMC8080416</ArticleId><ArticleId IdType="pubmed">33915108</ArticleId></ArticleIdList></Reference><Reference><Citation>Peligero-Cruz C., Givony T., Seb&#xe9;-Pedr&#xf3;s A., Dobe&#x161; J., Kadouri N., Nevo S., Roncato F., Alon R., Goldfarb Y., Abramson J. IL18 Signaling Promotes Homing of Mature Tregs into the Thymus. ELife. 2020;9:e58213. doi: 10.7554/eLife.58213.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.58213</ArticleId><ArticleId IdType="pmc">PMC7371425</ArticleId><ArticleId IdType="pubmed">32687059</ArticleId></ArticleIdList></Reference><Reference><Citation>Buckley P.R., Lee C.H., Pereira Pinho M., Ottakandathil Babu R., Woo J., Antanaviciute A., Simmons A., Ogg G., Koohy H. HLA-dependent Variation in SARS-CoV-2 CD8+ T Cell Cross-reactivity with Human Coronaviruses. Immunology. 2022;166:78&#x2013;103. doi: 10.1111/imm.13451.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.13451</ArticleId><ArticleId IdType="pmc">PMC9111820</ArticleId><ArticleId IdType="pubmed">35143694</ArticleId></ArticleIdList></Reference><Reference><Citation>Overacre-Delgoffe A.E., Chikina M., Dadey R.E., Yano H., Brunazzi E.A., Shayan G., Horne W., Moskovitz J.M., Kolls J.K., Sander C., et al. Interferon-&#x3b3; Drives Treg Fragility to Promote Anti-Tumor Immunity. Cell. 2017;169:1130&#x2013;1141.e11. doi: 10.1016/j.cell.2017.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.05.005</ArticleId><ArticleId IdType="pmc">PMC5509332</ArticleId><ArticleId IdType="pubmed">28552348</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J., Zhang E., Zhong M., Yang Q., Hong K., Shu T., Zhou D., Xiang J., Xia J., Zhou X., et al. Longitudinal Characteristics of T Cell Responses in Asymptomatic SARS-CoV-2 Infection. Virol. Sin. 2020;35:838&#x2013;841. doi: 10.1007/s12250-020-00277-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12250-020-00277-4</ArticleId><ArticleId IdType="pmc">PMC7441833</ArticleId><ArticleId IdType="pubmed">32822061</ArticleId></ArticleIdList></Reference><Reference><Citation>Benamar M., Chen Q., Chou J., Jul&#xe9; A.M., Boudra R., Contini P., Crestani E., Lai P.S., Wang M., Fong J., et al. The Notch1/CD22 Signaling Axis Disrupts Treg Function in SARS-CoV-2&#x2013;Associated Multisystem Inflammatory Syndrome in Children. J. Clin. Investig. 2023;133:e163235. doi: 10.1172/JCI163235.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI163235</ArticleId><ArticleId IdType="pmc">PMC9797337</ArticleId><ArticleId IdType="pubmed">36282598</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan W., Ni Z., Hu Y., Liang W., Ou C., He J., Liu L., Shan H., Lei C., Hui D.S.C., et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N. Engl. J. Med. 2020;382:1708&#x2013;1720. doi: 10.1056/NEJMoa2002032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2002032</ArticleId><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A., Madhavan M.V., Sehgal K., Nair N., Mahajan S., Sehrawat T.S., Bikdeli B., Ahluwalia N., Ausiello J.C., Wan E.Y., et al. Extrapulmonary Manifestations of COVID-19. Nat. Med. 2020;26:1017&#x2013;1032. doi: 10.1038/s41591-020-0968-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0968-3</ArticleId><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackermann M., Verleden S.E., Kuehnel M., Haverich A., Welte T., Laenger F., Vanstapel A., Werlein C., Stark H., Tzankov A., et al. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in COVID-19. N. Engl. J. Med. 2020;383:120&#x2013;128. doi: 10.1056/NEJMoa2015432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2015432</ArticleId><ArticleId IdType="pmc">PMC7412750</ArticleId><ArticleId IdType="pubmed">32437596</ArticleId></ArticleIdList></Reference><Reference><Citation>Henderson L.A., Canna S.W., Schulert G.S., Volpi S., Lee P.Y., Kernan K.F., Caricchio R., Mahmud S., Hazen M.M., Halyabar O., et al. On the Alert for Cytokine Storm: Immunopathology in COVID-19. Arthritis Rheumatol. 2020;72:1059&#x2013;1063. doi: 10.1002/art.41285.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.41285</ArticleId><ArticleId IdType="pmc">PMC7262347</ArticleId><ArticleId IdType="pubmed">32293098</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering A.V., van Zon S.K.R., olde Hartman T.C., Rosmalen J.G.M. Persistence of Somatic Symptoms after COVID-19 in the Netherlands: An Observational Cohort Study. Lancet. 2022;400:452&#x2013;461. doi: 10.1016/S0140-6736(22)01214-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01214-4</ArticleId><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V. A Clinical Case Definition of Post-COVID-19 Condition by a Delphi Consensus. Lancet Infect. Dis. 2022;22:e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqbal F.M., Lam K., Sounderajah V., Clarke J.M., Ashrafian H., Darzi A. Characteristics and Predictors of Acute and Chronic Post-COVID Syndrome: A Systematic Review and Meta-Analysis. eClinicalMedicine. 2021;36:100899. doi: 10.1016/j.eclinm.2021.100899.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.100899</ArticleId><ArticleId IdType="pmc">PMC8141371</ArticleId><ArticleId IdType="pubmed">34036253</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re&#x2019;em Y., Redfield S., Austin J.P., Akrami A. Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Impact. eClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Giszas B., Trommer S., Sch&#xfc;&#xdf;ler N., Rodewald A., Besteher B., Bleidorn J., Dickmann P., Finke K., Katzer K., Lehmann-Pohl K., et al. Post-COVID-19 Condition Is Not Only a Question of Persistent Symptoms: Structured Screening Including Health-Related Quality of Life Reveals Two Separate Clusters of Post-COVID. Infection. 2022 doi: 10.1007/s15010-022-01886-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-022-01886-9</ArticleId><ArticleId IdType="pmc">PMC9307219</ArticleId><ArticleId IdType="pubmed">35869353</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad M., Blish C.A., Sallusto F., Iwasaki A. The Immunology and Immunopathology of COVID-19. Science. 2022;375:1122&#x2013;1127. doi: 10.1126/science.abm8108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm8108</ArticleId><ArticleId IdType="pubmed">35271343</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun B., Tang N., Peluso M.J., Iyer N.S., Torres L., Donatelli J.L., Munter S.E., Nixon C.C., Rutishauser R.L., Rodriguez-Barraquer I., et al. Characterization and Biomarker Analyses of Post-COVID-19 Complications and Neurological Manifestations. Cells. 2021;10:386. doi: 10.3390/cells10020386.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10020386</ArticleId><ArticleId IdType="pmc">PMC7918597</ArticleId><ArticleId IdType="pubmed">33668514</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., Lu S., Tang A.F., Durstenfeld M.S., Ho H., Goldberg S.A., Forman C.A., Munter S.E., Hoh R., Tai V., et al. Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection. J. Infect. Dis. 2021;224:1839&#x2013;1848. doi: 10.1093/infdis/jiab490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab490</ArticleId><ArticleId IdType="pmc">PMC8643408</ArticleId><ArticleId IdType="pubmed">34677601</ArticleId></ArticleIdList></Reference><Reference><Citation>Gal&#xe1;n M., Vig&#xf3;n L., Fuertes D., Murciano-Ant&#xf3;n M.A., Casado-Fern&#xe1;ndez G., Dom&#xed;nguez-Mateos S., Mateos E., Ramos-Mart&#xed;n F., Planelles V., Torres M., et al. Persistent Overactive Cytotoxic Immune Response in a Spanish Cohort of Individuals With Long-COVID: Identification of Diagnostic Biomarkers. Front. Immunol. 2022;13:848886. doi: 10.3389/fimmu.2022.848886.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.848886</ArticleId><ArticleId IdType="pmc">PMC8990790</ArticleId><ArticleId IdType="pubmed">35401523</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson B.K., Guevara-Coto J., Yogendra R., Francisco E.B., Long E., Pise A., Rodrigues H., Parikh P., Mora J., Mora-Rodr&#xed;guez R.A. Immune-Based Prediction of COVID-19 Severity and Chronicity Decoded Using Machine Learning. Front. Immunol. 2021;12:700782. doi: 10.3389/fimmu.2021.700782.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.700782</ArticleId><ArticleId IdType="pmc">PMC8273732</ArticleId><ArticleId IdType="pubmed">34262570</ArticleId></ArticleIdList></Reference><Reference><Citation>Utrero-Rico A., Ruiz-Ruig&#xf3;mez M., Laguna-Goya R., Arrieta-Ortubay E., Chivite-Lacaba M., Gonz&#xe1;lez-Cuadrado C., Lalueza A., Almendro-Vazquez P., Serrano A., Aguado J.M., et al. A Short Corticosteroid Course Reduces Symptoms and Immunological Alterations Underlying Long-COVID. Biomedicines. 2021;9:1540. doi: 10.3390/biomedicines9111540.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9111540</ArticleId><ArticleId IdType="pmc">PMC8614904</ArticleId><ArticleId IdType="pubmed">34829769</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrara M.R., Bonfante F., Costenaro P., Cantarutti A., Carmona F., Ruffoni E., Di Chiara C., Zanchetta M., Barzon L., Don&#xe0; D., et al. Asymptomatic and Mild SARS-CoV-2 Infections Elicit Lower Immune Activation and Higher Specific Neutralizing Antibodies in Children Than in Adults. Front. Immunol. 2021;12:741796. doi: 10.3389/fimmu.2021.741796.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.741796</ArticleId><ArticleId IdType="pmc">PMC8515185</ArticleId><ArticleId IdType="pubmed">34659235</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan F.J., Hope C.M., Masavuli M.G., Lynn M.A., Mekonnen Z.A., Yeow A.E.L., Garcia-Valtanen P., Al-Delfi Z., Gummow J., Ferguson C., et al. Long-Term Perturbation of the Peripheral Immune System Months after SARS-CoV-2 Infection. BMC Med. 2022;20:26. doi: 10.1186/s12916-021-02228-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-02228-6</ArticleId><ArticleId IdType="pmc">PMC8758383</ArticleId><ArticleId IdType="pubmed">35027067</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiech M., Chroscicki P., Swatler J., Stepnik D., De Biasi S., Hampel M., Brewinska-Olchowik M., Maliszewska A., Sklinda K., Durlik M., et al. Remodeling of T Cell Dynamics During Long COVID Is Dependent on Severity of SARS-CoV-2 Infection. Front. Immunol. 2022;13:886431. doi: 10.3389/fimmu.2022.886431.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.886431</ArticleId><ArticleId IdType="pmc">PMC9226563</ArticleId><ArticleId IdType="pubmed">35757700</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Gasalla M., Berman-Riu M., Pons J., Rodr&#xed;guez A., Iglesias A., Mart&#xed;nez-Pomar N., Llompart-Alabern I., Riera M., Ferr&#xe9; Beltr&#xe1;n A., Figueras-Castilla A., et al. Hyperinflammatory State and Low T1 Adaptive Immune Response in Severe and Critical Acute COVID-19 Patients. Front. Med. 2022;9:828678. doi: 10.3389/fmed.2022.828678.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.828678</ArticleId><ArticleId IdType="pmc">PMC9002349</ArticleId><ArticleId IdType="pubmed">35425776</ArticleId></ArticleIdList></Reference><Reference><Citation>Suvvari T.K., Kutikuppala L.V.S., Tsagkaris C., Corriero A.C., Kandi V. Post-COVID-19 Complications: Multisystemic Approach. J. Med. Virol. 2021;93:6451&#x2013;6455. doi: 10.1002/jmv.27222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27222</ArticleId><ArticleId IdType="pmc">PMC8427008</ArticleId><ArticleId IdType="pubmed">34289162</ArticleId></ArticleIdList></Reference><Reference><Citation>St&#xe5;hlberg M., Reistam U., Fedorowski A., Villacorta H., Horiuchi Y., Bax J., Pitt B., Matskeplishvili S., L&#xfc;scher T.F., Weichert I., et al. Post-COVID-19 Tachycardia Syndrome: A Distinct Phenotype of Post-Acute COVID-19 Syndrome. Am. J. Med. 2021;134:1451&#x2013;1456. doi: 10.1016/j.amjmed.2021.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2021.07.004</ArticleId><ArticleId IdType="pmc">PMC8356730</ArticleId><ArticleId IdType="pubmed">34390682</ArticleId></ArticleIdList></Reference><Reference><Citation>Afrin L.B., Weinstock L.B., Molderings G.J. COVID--19 Hyperinflammation and Post-COVID--19 Illness May Be Rooted in Mast Cell Activation Syndrome. Int. J. Infect. Dis. 2020;100:327&#x2013;332. doi: 10.1016/j.ijid.2020.09.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.09.016</ArticleId><ArticleId IdType="pmc">PMC7529115</ArticleId><ArticleId IdType="pubmed">32920235</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker M., Elliott J., Chadeau-Hyam M., Riley S., Darzi A., Cooke G., Ward H., Elliott P. Persistent COVID-19 Symptoms in a Community Study of 606,434 People in England. Nat. Commun. 2022;13:1957. doi: 10.1038/s41467-022-29521-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29521-z</ArticleId><ArticleId IdType="pmc">PMC9005552</ArticleId><ArticleId IdType="pubmed">35413949</ArticleId></ArticleIdList></Reference><Reference><Citation>Hefazi M., Bolivar-Wagers S., Blazar B.R. Regulatory T Cell Therapy of Graft-versus-Host Disease: Advances and Challenges. Int. J. Mol. Sci. 2021;22:9676. doi: 10.3390/ijms22189676.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22189676</ArticleId><ArticleId IdType="pmc">PMC8469916</ArticleId><ArticleId IdType="pubmed">34575843</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J., Han Z.-B., Liao W., Yang S.G., Yang Z., Yu J., Meng L., Wu R., Han Z.C. Intrapulmonary Delivery of Human Umbilical Cord Mesenchymal Stem Cells Attenuates Acute Lung Injury by Expanding CD4+CD25+ Forkhead Boxp3 (FOXP3) + Regulatory T Cells and Balancing Anti- and Pro-Inflammatory Factors. Cell. Physiol. Biochem. 2011;27:587&#x2013;596. doi: 10.1159/000329980.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000329980</ArticleId><ArticleId IdType="pubmed">21691076</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Y., Xu W., Xiong S. Adoptive Transfer of Regulatory T Cells Protects against Coxsackievirus B3-Induced Cardiac Fibrosis. PLoS ONE. 2013;8:e74955. doi: 10.1371/journal.pone.0074955.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0074955</ArticleId><ArticleId IdType="pmc">PMC3762771</ArticleId><ArticleId IdType="pubmed">24023968</ArticleId></ArticleIdList></Reference><Reference><Citation>Gladstone D.E., Kim B.S., Mooney K., Karaba A.H., D&#x2019;Alessio F.R. Regulatory T Cells for Treating Patients With COVID-19 and Acute Respiratory Distress Syndrome: Two Case Reports. Ann. Intern. Med. 2020;173:852&#x2013;853. doi: 10.7326/L20-0681.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/L20-0681</ArticleId><ArticleId IdType="pmc">PMC7370819</ArticleId><ArticleId IdType="pubmed">32628535</ArticleId></ArticleIdList></Reference><Reference><Citation>Hossein-khannazer N., Shokoohian B., Shpichka A., Aghdaei H.A., Timashev P., Vosough M. An Update to &#x201c;Novel Therapeutic Approaches for Treatment of COVID-19&#x201d;. J. Mol. Med. 2021;99:303&#x2013;310. doi: 10.1007/s00109-020-02027-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00109-020-02027-1</ArticleId><ArticleId IdType="pmc">PMC7779099</ArticleId><ArticleId IdType="pubmed">33392632</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Wang X., Li X., Xi D., Mao R., Wu X., Cheng S., Sun X., Yi C., Ling Z., et al. Potential Contribution of Increased Soluble IL-2R to Lymphopenia in COVID-19 Patients. Cell. Mol. Immunol. 2020;17:878&#x2013;880. doi: 10.1038/s41423-020-0484-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-0484-x</ArticleId><ArticleId IdType="pmc">PMC7315399</ArticleId><ArticleId IdType="pubmed">32587367</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabaan A.A., Al-Ahmed S.H., Muhammad J., Khan A., Sule A.A., Tirupathi R., Mutair A.A., Alhumaid S., Al-Omari A., Dhawan M., et al. Role of Inflammatory Cytokines in COVID-19 Patients: A Review on Molecular Mechanisms, Immune Functions, Immunopathology and Immunomodulatory Drugs to Counter Cytokine Storm. Vaccines. 2021;9:436. doi: 10.3390/vaccines9050436.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9050436</ArticleId><ArticleId IdType="pmc">PMC8145892</ArticleId><ArticleId IdType="pubmed">33946736</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartemann A., Bensimon G., Payan C.A., Jacqueminet S., Bourron O., Nicolas N., Fonfrede M., Rosenzwajg M., Bernard C., Klatzmann D. Low-Dose Interleukin 2 in Patients with Type 1 Diabetes: A Phase 1/2 Randomised, Double-Blind, Placebo-Controlled Trial. Lancet Diabetes Endocrinol. 2013;1:295&#x2013;305. doi: 10.1016/S2213-8587(13)70113-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(13)70113-X</ArticleId><ArticleId IdType="pubmed">24622415</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy-Nasser A.A., Ku S., Castillo-Caro P., Hazrat Y., Wu M.-F., Liu H., Melenhorst J., Barrett A.J., Ito S., Foster A., et al. Ultra Low-Dose IL-2 for GVHD Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation Mediates Expansion of Regulatory T Cells without Diminishing Antiviral and Antileukemic Activity. Clin. Cancer Res. 2014;20:2215&#x2013;2225. doi: 10.1158/1078-0432.CCR-13-3205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1078-0432.CCR-13-3205</ArticleId><ArticleId IdType="pmc">PMC3989436</ArticleId><ArticleId IdType="pubmed">24573552</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu M.-E., Wang Q., Zhou S., Wang B., Ke L., He P. Recombinant Interleukin-2 Stimulates Lymphocyte Recovery in Patients with Severe COVID-19. Exp. Ther. Med. 2021;21:227. doi: 10.3892/etm.2021.9658.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2021.9658</ArticleId><ArticleId IdType="pmc">PMC7851620</ArticleId><ArticleId IdType="pubmed">33603836</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou H., Zhang B., Huang H., Luo Y., Wu S., Tang G., Liu W., Mao L., Mao L., Wang F., et al. Using IL-2R/Lymphocytes for Predicting the Clinical Progression of Patients with COVID-19. Clin. Exp. Immunol. 2020;201:76&#x2013;84. doi: 10.1111/cei.13450.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cei.13450</ArticleId><ArticleId IdType="pmc">PMC7267633</ArticleId><ArticleId IdType="pubmed">32365221</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang H.J., Leem A.Y., Chung K.S., Ahn J.Y., Jung J.Y., Kang Y.A., Park M.S., Kim Y.S., Lee S.H. Soluble IL-2R Levels Predict in-Hospital Mortality in COVID-19 Patients with Respiratory Failure. J. Clin. Med. 2021;10:4242. doi: 10.3390/jcm10184242.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10184242</ArticleId><ArticleId IdType="pmc">PMC8471426</ArticleId><ArticleId IdType="pubmed">34575353</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephen-Victor E., Das M., Karnam A., Pitard B., Gautier J.-F., Bayry J. Potential of Regulatory T-Cell-Based Therapies in the Management of Severe COVID-19. Eur. Respir. J. 2020;56:2002182. doi: 10.1183/13993003.02182-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02182-2020</ArticleId><ArticleId IdType="pmc">PMC7331657</ArticleId><ArticleId IdType="pubmed">32616599</ArticleId></ArticleIdList></Reference><Reference><Citation>Trotta E., Bessette P.H., Silveria S.L., Ely L.K., Jude K.M., Le D.T., Holst C.R., Coyle A., Potempa M., Lanier L.L., et al. A Human Anti-IL-2 Antibody That Potentiates Regulatory T Cells by a Structure-Based Mechanism. Nat. Med. 2018;24:1005&#x2013;1014. doi: 10.1038/s41591-018-0070-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-018-0070-2</ArticleId><ArticleId IdType="pmc">PMC6398608</ArticleId><ArticleId IdType="pubmed">29942088</ArticleId></ArticleIdList></Reference><Reference><Citation>Webster K.E., Walters S., Kohler R.E., Mrkvan T., Boyman O., Surh C.D., Grey S.T., Sprent J. In Vivo Expansion of T Reg Cells with IL-2&#x2013;mAb Complexes: Induction of Resistance to EAE and Long-Term Acceptance of Islet Allografts without Immunosuppression. J. Exp. Med. 2009;206:751&#x2013;760. doi: 10.1084/jem.20082824.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20082824</ArticleId><ArticleId IdType="pmc">PMC2715127</ArticleId><ArticleId IdType="pubmed">19332874</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosseini A., Gharibi T., Mohammadzadeh A., Ebrahimi-kalan A., Jadidi-niaragh F., Babaloo Z., Shanehbandi D., Baghbani E., Baradaran B. Ruxolitinib Attenuates Experimental Autoimmune Encephalomyelitis (EAE) Development as Animal Models of Multiple Sclerosis (MS) Life Sci. 2021;276:119395. doi: 10.1016/j.lfs.2021.119395.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2021.119395</ArticleId><ArticleId IdType="pubmed">33781828</ArticleId></ArticleIdList></Reference><Reference><Citation>Uraki R., Imai M., Ito M., Shime H., Odanaka M., Okuda M., Kawaoka Y., Yamazaki S. Foxp3+ CD4+ Regulatory T Cells Control Dendritic Cells in Inducing Antigen-Specific Immunity to Emerging SARS-CoV-2 Antigens. PLOS Pathog. 2021;17:e1010085. doi: 10.1371/journal.ppat.1010085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1010085</ArticleId><ArticleId IdType="pmc">PMC8659413</ArticleId><ArticleId IdType="pubmed">34882757</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng H., Wang L., Yang B., Li D., Wang X., Liu X., Tian N., Huang Q., Feng R., Wang Z., et al. Cutting Edge: Inhibition of Glycogen Synthase Kinase 3 Activity Induces the Generation and Enhanced Suppressive Function of Human IL-10+ FOXP3+&#x2013;Induced Regulatory T Cells. J. Immunol. 2020;205:1497&#x2013;1502. doi: 10.4049/jimmunol.2000136.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.2000136</ArticleId><ArticleId IdType="pmc">PMC7477744</ArticleId><ArticleId IdType="pubmed">32817370</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudd C.E. GSK-3 Inhibition as a Therapeutic Approach Against SARs CoV2: Dual Benefit of Inhibiting Viral Replication While Potentiating the Immune Response. Front. Immunol. 2020;11:1638. doi: 10.3389/fimmu.2020.01638.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01638</ArticleId><ArticleId IdType="pmc">PMC7333796</ArticleId><ArticleId IdType="pubmed">32695123</ArticleId></ArticleIdList></Reference><Reference><Citation>Sauer S., Bruno L., Hertweck A., Finlay D., Leleu M., Spivakov M., Knight Z.A., Cobb B.S., Cantrell D., O&#x2019;Connor E., et al. T Cell Receptor Signaling Controls Foxp3 Expression via PI3K, Akt, and mTOR. Proc. Natl. Acad. Sci. USA. 2008;105:7797&#x2013;7802. doi: 10.1073/pnas.0800928105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0800928105</ArticleId><ArticleId IdType="pmc">PMC2409380</ArticleId><ArticleId IdType="pubmed">18509048</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeiser R., Leveson-Gower D.B., Zambricki E.A., Kambham N., Beilhack A., Loh J., Hou J.-Z., Negrin R.S. Differential Impact of Mammalian Target of Rapamycin Inhibition on CD4+CD25+Foxp3+ Regulatory T Cells Compared with Conventional CD4+ T Cells. Blood. 2008;111:453&#x2013;462. doi: 10.1182/blood-2007-06-094482.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2007-06-094482</ArticleId><ArticleId IdType="pmc">PMC2200823</ArticleId><ArticleId IdType="pubmed">17967941</ArticleId></ArticleIdList></Reference><Reference><Citation>Battaglia M., Stabilini A., Migliavacca B., Horejs-Hoeck J., Kaupper T., Roncarolo M.-G. Rapamycin Promotes Expansion of Functional CD4+CD25+FOXP3+ Regulatory T Cells of Both Healthy Subjects and Type 1 Diabetic Patients. J. Immunol. 2006;177:8338&#x2013;8347. doi: 10.4049/jimmunol.177.12.8338.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.177.12.8338</ArticleId><ArticleId IdType="pubmed">17142730</ArticleId></ArticleIdList></Reference><Reference><Citation>Bischof E., Siow R.C., Zhavoronkov A., Kaeberlein M. The Potential of Rapalogs to Enhance Resilience against SARS-CoV-2 Infection and Reduce the Severity of COVID-19. Lancet Healthy Longev. 2021;2:e105&#x2013;e111. doi: 10.1016/S2666-7568(20)30068-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-7568(20)30068-4</ArticleId><ArticleId IdType="pmc">PMC7906698</ArticleId><ArticleId IdType="pubmed">33665645</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu L., Lan Q., Li Z., Zhou X., Gu J., Li Q., Wang J., Chen M., Liu Y., Shen Y., et al. Critical Role of All&#x2014;Trans Retinoic Acid in Stabilizing Human Natural Regulatory T Cells under Inflammatory Conditions. Proc. Natl. Acad. Sci. USA. 2014;111:E3432&#x2013;E3440. doi: 10.1073/pnas.1408780111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1408780111</ArticleId><ArticleId IdType="pmc">PMC4143025</ArticleId><ArticleId IdType="pubmed">25099355</ArticleId></ArticleIdList></Reference><Reference><Citation>Elias K.M., Laurence A., Davidson T.S., Stephens G., Kanno Y., Shevach E.M., O&#x2019;Shea J.J. Retinoic Acid Inhibits Th17 Polarization and Enhances FoxP3 Expression through a Stat-3/Stat-5 Independent Signaling Pathway. Blood. 2008;111:1013&#x2013;1020. doi: 10.1182/blood-2007-06-096438.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2007-06-096438</ArticleId><ArticleId IdType="pmc">PMC2214761</ArticleId><ArticleId IdType="pubmed">17951529</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou X., Kong N., Wang J., Fan H., Zou H., Horwitz D., Brand D., Liu Z., Zheng S.G. Cutting Edge: All-Trans Retinoic Acid Sustains the Stability and Function of Natural Regulatory T Cells in an Inflammatory Milieu. J. Immunol. 2010;185:2675&#x2013;2679. doi: 10.4049/jimmunol.1000598.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1000598</ArticleId><ArticleId IdType="pmc">PMC3098624</ArticleId><ArticleId IdType="pubmed">20679534</ArticleId></ArticleIdList></Reference><Reference><Citation>Morita T., Miyakawa K., Jeremiah S.S., Yamaoka Y., Sada M., Kuniyoshi T., Yang J., Kimura H., Ryo A. All-Trans Retinoic Acid Exhibits Antiviral Effect against SARS-CoV-2 by Inhibiting 3CLpro Activity. Viruses. 2021;13:1669. doi: 10.3390/v13081669.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13081669</ArticleId><ArticleId IdType="pmc">PMC8402917</ArticleId><ArticleId IdType="pubmed">34452533</ArticleId></ArticleIdList></Reference><Reference><Citation>Eggenhuizen P.J., Ng B.H., Ooi J.D. Treg Enhancing Therapies to Treat Autoimmune Diseases. Int. J. Mol. Sci. 2020;21:7015. doi: 10.3390/ijms21197015.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21197015</ArticleId><ArticleId IdType="pmc">PMC7582931</ArticleId><ArticleId IdType="pubmed">32977677</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang Q., Henriksen K.J., Bi M., Finger E.B., Szot G., Ye J., Masteller E.L., McDevitt H., Bonyhadi M., Bluestone J.A. In Vitro&#x2013;Expanded Antigen-Specific Regulatory T Cells Suppress Autoimmune Diabetes. J. Exp. Med. 2004;199:1455&#x2013;1465. doi: 10.1084/jem.20040139.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20040139</ArticleId><ArticleId IdType="pmc">PMC2211775</ArticleId><ArticleId IdType="pubmed">15184499</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright G.P., Notley C.A., Xue S.-A., Bendle G.M., Holler A., Schumacher T.N., Ehrenstein M.R., Stauss H.J. Adoptive Therapy with Redirected Primary Regulatory T Cells Results in Antigen-Specific Suppression of Arthritis. Proc. Natl. Acad. Sci. USA. 2009;106:19078&#x2013;19083. doi: 10.1073/pnas.0907396106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0907396106</ArticleId><ArticleId IdType="pmc">PMC2776462</ArticleId><ArticleId IdType="pubmed">19884493</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsang J.Y.-S., Tanriver Y., Jiang S., Xue S.-A., Ratnasothy K., Chen D., Stauss H.J., Bucy R.P., Lombardi G., Lechler R. Conferring Indirect Allospecificity on CD4+CD25+ Tregs by TCR Gene Transfer Favors Transplantation Tolerance in Mice. J. Clin. Investig. 2008;118:3619&#x2013;3628. doi: 10.1172/JCI33185.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI33185</ArticleId><ArticleId IdType="pmc">PMC2564608</ArticleId><ArticleId IdType="pubmed">18846251</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q., Lu W., Liang C.-L., Chen Y., Liu H., Qiu F., Dai Z. Chimeric Antigen Receptor (CAR) Treg: A Promising Approach to Inducing Immunological Tolerance. Front. Immunol. 2018;9:2359. doi: 10.3389/fimmu.2018.02359.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02359</ArticleId><ArticleId IdType="pmc">PMC6194362</ArticleId><ArticleId IdType="pubmed">30369931</ArticleId></ArticleIdList></Reference><Reference><Citation>Fransson M., Piras E., Burman J., Nilsson B., Essand M., Lu B., Harris R.A., Magnusson P.U., Brittebo E., Loskog A.S. CAR/FoxP3-Engineered T Regulatory Cells Target the CNS and Suppress EAE upon Intranasal Delivery. J. Neuroinflammation. 2012;9:112. doi: 10.1186/1742-2094-9-112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-9-112</ArticleId><ArticleId IdType="pmc">PMC3403996</ArticleId><ArticleId IdType="pubmed">22647574</ArticleId></ArticleIdList></Reference><Reference><Citation>Blat D., Zigmond E., Alteber Z., Waks T., Eshhar Z. Suppression of Murine Colitis and Its Associated Cancer by Carcinoembryonic Antigen-Specific Regulatory T Cells. Mol. Ther. 2014;22:1018&#x2013;1028. doi: 10.1038/mt.2014.41.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mt.2014.41</ArticleId><ArticleId IdType="pmc">PMC4015241</ArticleId><ArticleId IdType="pubmed">24686242</ArticleId></ArticleIdList></Reference><Reference><Citation>Skuljec J., Chmielewski M., Happle C., Habener A., Busse M., Abken H., Hansen G. Chimeric Antigen Receptor-Redirected Regulatory T Cells Suppress Experimental Allergic Airway Inflammation, a Model of Asthma. Front. Immunol. 2017;8:1125. doi: 10.3389/fimmu.2017.01125.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.01125</ArticleId><ArticleId IdType="pmc">PMC5600908</ArticleId><ArticleId IdType="pubmed">28955341</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelena X., Borrell H., L&#xf3;pez-Corbeto M., L&#xf3;pez-Lasanta M., Moreno E., Pascual-Pastor M., Erra A., Serrat M., Espartal E., Ant&#xf3;n S., et al. Incidence of COVID-19 in a Cohort of Adult and Paediatric Patients with Rheumatic Diseases Treated with Targeted Biologic and Synthetic Disease-Modifying Anti-Rheumatic Drugs. Semin. Arthritis Rheum. 2020;50:564&#x2013;570. doi: 10.1016/j.semarthrit.2020.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2020.05.001</ArticleId><ArticleId IdType="pmc">PMC7229730</ArticleId><ArticleId IdType="pubmed">32425260</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaz de Paula C.B., Nagashima S., Liberalesso V., Collete M., da Silva F.P.G., Oricil A.G.G., Barbosa G.S., da Silva G.V.C., Wiedmer D.B., da Silva Dezid&#xe9;rio F., et al. COVID-19: Immunohistochemical Analysis of TGF-&#x3b2; Signaling Pathways in Pulmonary Fibrosis. Int. J. Mol. Sci. 2021;23:168. doi: 10.3390/ijms23010168.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23010168</ArticleId><ArticleId IdType="pmc">PMC8745764</ArticleId><ArticleId IdType="pubmed">35008594</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen W. A Potential Treatment of COVID-19 with TGF-&#x3b2; Blockade. Int. J. Biol. Sci. 2020;16:1954&#x2013;1955. doi: 10.7150/ijbs.46891.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.46891</ArticleId><ArticleId IdType="pmc">PMC7211163</ArticleId><ArticleId IdType="pubmed">32398962</ArticleId></ArticleIdList></Reference><Reference><Citation>He J., Zhang R., Shao M., Zhao X., Miao M., Chen J., Liu J., Zhang X., Zhang X., Jin Y., et al. Efficacy and Safety of Low-Dose IL-2 in the Treatment of Systemic Lupus Erythematosus: A Randomised, Double-Blind, Placebo-Controlled Trial. Ann. Rheum. Dis. 2019;79:141&#x2013;149. doi: 10.1136/annrheumdis-2019-215396.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2019-215396</ArticleId><ArticleId IdType="pmc">PMC6937406</ArticleId><ArticleId IdType="pubmed">31537547</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaudhary B., Elkord E. Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic Targeting. Vaccines. 2016;4:28. doi: 10.3390/vaccines4030028.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines4030028</ArticleId><ArticleId IdType="pmc">PMC5041022</ArticleId><ArticleId IdType="pubmed">27509527</ArticleId></ArticleIdList></Reference><Reference><Citation>Gliwi&#x144;ski M., Iwaszkiewicz-Grze&#x15b; D., Trzonkowski P. Cell-Based Therapies with T Regulatory Cells. BioDrugs. 2017;31:335&#x2013;347. doi: 10.1007/s40259-017-0228-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40259-017-0228-3</ArticleId><ArticleId IdType="pmc">PMC5548816</ArticleId><ArticleId IdType="pubmed">28540499</ArticleId></ArticleIdList></Reference><Reference><Citation>Ting H.-A., de Almeida Nagata D., Rasky A.J., Malinczak C.-A., Maillard I.P., Schaller M.A., Lukacs N.W. Notch Ligand Delta-like 4 Induces Epigenetic Regulation of Treg Cell Differentiation and Function in Viral Infection. Mucosal Immunol. 2018;11:1524&#x2013;1536. doi: 10.1038/s41385-018-0052-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41385-018-0052-1</ArticleId><ArticleId IdType="pmc">PMC6160345</ArticleId><ArticleId IdType="pubmed">30038214</ArticleId></ArticleIdList></Reference><Reference><Citation>Batah S.S., Fabro A.T. Pulmonary Pathology of ARDS in COVID-19: A Pathological Review for Clinicians. Respir. Med. 2021;176:106239. doi: 10.1016/j.rmed.2020.106239.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2020.106239</ArticleId><ArticleId IdType="pmc">PMC7674971</ArticleId><ArticleId IdType="pubmed">33246294</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu G., Qi F., Li H., Yang Q., Wang H., Wang X., Liu X., Zhao J., Liao X., Liu Y., et al. The Differential Immune Responses to COVID-19 in Peripheral and Lung Revealed by Single-Cell RNA Sequencing. Cell Discov. 2020;6:73. doi: 10.1038/s41421-020-00225-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41421-020-00225-2</ArticleId><ArticleId IdType="pmc">PMC7574992</ArticleId><ArticleId IdType="pubmed">33101705</ArticleId></ArticleIdList></Reference><Reference><Citation>Alahyari S., Rajaeinejad M., Jalaeikhoo H., Amani D. Regulatory T Cells in Immunopathogenesis and Severity of COVID-19: A Systematic Review. Arch. Iran. Med. 2022;25:127&#x2013;132. doi: 10.34172/aim.2022.22.</Citation><ArticleIdList><ArticleId IdType="doi">10.34172/aim.2022.22</ArticleId><ArticleId IdType="pubmed">35429952</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>